OCREVUS
As listed in the register: OCREVUS 300 mg, solution à diluer pour perfusion
300 mg · solution à diluer pour perfusion
- Prescription only
- Active substance
- Ocrélizumab
- Made by
- ROCHE REGISTRATION (ALLEMAGNE)
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | ROCHE REGISTRATION (ALLEMAGNE) |
|---|---|
| Active substance | Ocrélizumab |
| Strength | 300 mg |
| Form | solution à diluer pour perfusion |
| Route | intraveineuse |
| Dispensing (as stated by the register) | réservé à l'usage HOSPITALIER · prescription réservée aux spécialistes et services NEUROLOGIE · médicament nécessitant une surveillance particulière pendant le traitement · liste I |
| Marketed | Yes, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/17/1231 |
| Name in the register | OCREVUS 300 mg, solution à diluer pour perfusion |
| Packs | 1 flacon en verre de 10 mL |
| CIS | 66127361 |
| CIP13 | 3400955048367 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).
Other strengths and forms
2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- solution à diluer pour perfusion1 products
- 300 mg
- solution injectable1 products
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.